chest diseases, including lung cancer, thymoma and esophageal cancer
Conditions
Interventions
Gold Standard:Pathological report is the gold standard for judging the disease in first discovery patients
Patients with recurrent lung cancer were subject to CT, PE-CT and other clinical comprehensive evaluation.
and 
machine 
learning 
Sponsors
The First Affiliated Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. The testing age is 18-80 years old, male or female; 2. Patients with malignant tumors in thoracic surgery and who have not received relevant treatment for malignant tumors; 3. First-episode patients need surgical resection to clarify the nature of the lesion; 4. Those who have undergone malignant tumor-related treatment or relapse can also be included, but they need to have a complete history of previous treatment; 5. Patients can fully understand the informed consent form and be able to sign the informed consent form in person.
Exclusion criteria
Exclusion criteria: 1. Those who fail to pass the breath sampling; 2. Suffering from other malignant tumors at the same time; 3. Patients with severe bronchial asthma and confirmed pulmonary tuberculosis; 4. Severe liver damage and kidney disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exhale volatile organic compound (VOC); | — |
Countries
China
Contacts
Public ContactChen Zhenguang
The First Affiliated Hospital of Sun Yat-sen University
Outcome results
None listed